Screener / SEC EDGAR /CIK 0001601830 /10-K filed Feb 25, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Recursion Pharmaceuticals, Inc. RXRX

Compare with peers Embed
Insider trades since May 20, 2026

5 insiders sold $1.4M on the market, none bought

Form 4
Bought on the market $0 0 trades
Sold on the market $1.4M 13 trades by 5 insiders
Sold under a 10b5-1 plan 100% of the value sold, under a plan set up in advance
Traded the most Blake Borgeson $864K Director

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$0 bought on 0 days, $1.4M sold on 11 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Blake Borgeson
Director
-$864K Nov 3, 2026
Christopher Gibson
Director
-$268K Jun 5, 2026
Najat Khan
CEO and President, Director
-$163K Sep 8, 2026
Robert Hershberg
Director
-$125K Oct 6, 2026
Namandje Bumpus
Director
-$28K Jun 18, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 13 open-market sales by officers and directors, 4 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Nov 3, 2026 Blake Borgeson Sale (10b5-1) -40,000 155K
Oct 6, 2026 Robert Hershberg Sale (10b5-1) -25,000 125K
Oct 6, 2026 Blake Borgeson Sale (10b5-1) -50,000 242K
Sep 8, 2026 Najat Khan Sale (10b5-1) -22,408 79K
Sep 1, 2026 Blake Borgeson Sale (10b5-1) -30,000 100K
Aug 4, 2026 Blake Borgeson Sale (10b5-1) -30,000 98K
Jul 7, 2026 Blake Borgeson Sale (10b5-1) -40,000 158K
Jun 18, 2026 Namandje Bumpus Sale (10b5-1) -3,963 13K
Jun 5, 2026 Christopher Gibson Sale (10b5-1) -40,000 145K
Jun 5, 2026 Najat Khan Sale (10b5-1) -23,588 84K
Jun 3, 2026 Namandje Bumpus Sale (10b5-1) -4,386 16K
Jun 2, 2026 Blake Borgeson Sale (10b5-1) -30,000 110K
May 22, 2026 Christopher Gibson Sale (10b5-1) -40,000 123K

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RXRX/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.